Primary Care Smoking Cessation. GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco
|
|
- Asher Thomas
- 6 years ago
- Views:
Transcription
1 Primary Care Smoking Cessation Dr John McMenamin GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco
2 Target or Tickbox? The Tobacco health target: 90% smokers attending practices given brief advice each year What s our role?
3 Tobacco use is the leading cause of preventable death in New Zealand, accounting for around 4300 to 4600 deaths per year. 1 Half of the people who smoke today and continue smoking will eventually be killed by tobacco. 2 Half of them will die in middle age. 3 Smoking causes one in four of all cancer deaths in New Zealand. 8 1 Peto, R., Lopez, A., et al. (2000). Mortality from Smoking in Developed Countries : Indirect estimates from national vital statistics. New York: Oxford University Press. 2 World Health Organization. Why is tobacco a public health priority? Tobacco Free Initiative. 8 Laugesen, M. (2000). Tobacco Statistics Wellington: Cancer Society of New Zealand
4 Smokers die early The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK Lancet January 12; 381(9861):
5 Quitting Works The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK Lancet January 12; 381(9861):
6 Tobacco plays a significant role in health inequalities within New Zealand. Higher smoking prevalence seen among lowincome groups, Māori and Pacific peoples Hill, S., Blakely, T., Howden-Chapman, P. (2003). Smoking Inequalities: Policies and patterns of tobacco use in New Zealand to Wellington: Ministry of Health.
7 90% of enrolled patients who smoke and are seen in General Practice, will be provided with advice and help to quit. Why the target was developed... Brief advice about doubles quit rates Cochrane database 2004/2008
8 % Patients making a quit attempt % patients making a quit attempt in 6 months following a GP visit No intervention Baseline 25 Brief advice to quit on medical grounds 35 Making an offer of treatment AVEYARD, P., R. BEGH, et al. (2011). "Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance." Addiction.
9 Acceptance of smoking cessation treatment by readiness to quit % of smokers Total N=2168 % of total Accepted treatment Abstinent at end of treatment (17 weeks) Ready to quit Not ready to quit PISINGER et al (2005) Prev Med, 40:
10 In a direct comparison, offering assistance generated more quit attempts than giving advice to quit on medical grounds more effective to offer cessation support to all smokers than by advising smokers to quit and offering assistance only to those who express an interest in doing so
11 stage-based interventions neither more nor less effective than the standard one.. These findings confirm the known effectiveness of these interventions, whether staged or unstaged.
12 NRT about doubles quit rates No overall difference in effectiveness of different forms of NRT Heavier smokers may need higher doses of NRT. People who use NRT during a quit attempt are likely to further increase their chance of success by using a combination of the nicotine patch and a faster acting form. Starting to use NRT shortly before the planned quit date may increase the chance of success.
13 NRT: Long-term (>6 month) quit rates vs. placebo Pooled 36 studies RR=1.60 (95% CI: ) Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD DOI: / CD pub4.
14 bupropion and nortriptyline aid longterm smoking cessation but selective serotonin reuptake inhibitors (e.g. fluoxetine) do not. Evidence suggests that the mode of action of bupropion and nortriptyline is independent of their antidepressant effect and that they are of similar efficacy to nicotine replacement. Adverse events with both medications appear to be rarely serious or lead to stopping medication.
15 Bupropion: Long-term (>6 month) quit rates vs. placebo Pooled 36 studies RR=1.69 (95% CI: ) Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD DOI: / CD pub3.
16 Nortriptyline: Long-term (>6 month) quit rates vs. placebo Pooled 6 studies RR=2.03 (95% CI ) Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD DOI: / CD pub3.
17 (14 trials, 6166 people), varenicline at standard dose increased the chances of quitting more than two-fold compared with placebo. Concerns re depressed mood, agitation, or suicidal thinking and behaviour in some smokers. Concerns that it may slightly increase heart and circulatory problems in people already at increased risk of these illnesses. Surveillance studies and further analyses of the trial data have not found strong support for either of these associations so far, but we cannot rule out the possibility of such links. Cochrane report 2012
18 Varenicline: Long-term (>6 month) quit rates vs. placebo Pooled 14 studies RR=2.27 (95% CI ) Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD DOI: / CD pub6.
19 Interventions that combine pharmacotherapy and behavioural support increase smoking cessation success compared to a minimal intervention or usual care. Cessation success not directly related to time spent per session More frequent sessions improve quit success Some people need intensive support
20 Quitting without support 100 % abstinent With support (behavioural + pharmacological) Days since quitting
21 neither reducing or abrupt quitting produced superior quit rates smokers should be given a choice of quitting methods, either reducing smoking before quitting or abrupt quitting Comparing reducing smoking to quit with abrupt quitting. Lindson-Hawley N, Aveyard P, Hughes JR Published Online: November 14,
22 Proactive Telephone Counselling RR=1.37, 95%CI: Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD DOI: / CD pub2
23 Mobile Phone (SMS Text) Support RR=1.71, 95%CI: Whittaker R,McRobbie H, Bullen C, Borland R, Rodgers A,Gu Y.Mobile phone-based interventions for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD DOI: / CD pub3
24 Health Targets 90% of enrolled patients who smoke and are seen in General Practice, will be provided with advice and help to quit. By July % By Oct % By Jan % By April % Message : targets focus attention and resources on good clinical practice and desired health outcomes
25
26 63% Impact of contacting patients on offering support ABC 40%
27 Effect of increased offering support on quit rates 24%
28 Most outreach activities yield: 10-20% of those contacted have already stopped 10-40% want to stop now 20% want to stop some time The rest are not ready just now
29 Recording smoking cessation support -> identifies the support for that person -> allows an audit of who else needs contact Making recording easy
30 Cessation pathway available
31 Reduction in Tobacco sales in NZ last 4 years: % 300 million fewer cigarettes sold each year % % %
32 Our role: Better help for smokers to stop Asking Brief advice and Cessation support For 650,000 smokers -> 20 per year per GP until : The Department of Health produced the first posters in New Zealand linking cancer with smoking
Effective Treatments for Tobacco Dependence
Effective Treatments for Tobacco Dependence Abigail Halperin MD, MPH Director, University of Washington Tobacco Studies Program Ken Wassum Associate Director of Clinical Development and Support Quit for
More informationPharmacological interventions for smoking cessation: an overview and network meta-analysis (Review)
Pharmacological interventions for smoking cessation: an overview and network meta-analysis (Review) Cahill K, Stevens S, Perera R, Lancaster T This is a reprint of a Cochrane review, prepared and maintained
More informationBest practice for brief tobacco cessation interventions. Hayden McRobbie The Dragon Institute for Innovation
Best practice for brief tobacco cessation interventions Hayden McRobbie The Dragon Institute for Innovation Disclosures I am Professor of Public Health Interventions at Queen Mary University of London
More informationBackground. Abstinence rates associated with varenicline
What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background
More informationDoes cigarette reduction while using nicotine replacement predict quitting? Observational evidence from the Rapid Reduction Trial
10 th UKSBM ASM; Nottingham 2014 Does cigarette reduction while using nicotine replacement predict quitting? Observational evidence from the Rapid Reduction Trial Lindson-Hawley N; West R; Michie S; Aveyard
More informationHEALTH TARGETS IN PRIMARY CARE
HEALTH TARGETS IN PRIMARY CARE MORE HEART AND DIABETES CHECKS BETTER HELP FOR SMOKERS TO QUIT Better Help for Smokers to Quit 90% of enrolled patients who smoke and are seen by General Practice, will be
More informationPharmacotherapy for Tobacco Dependence Treatment
Pharmacotherapy for Tobacco Dependence Treatment Nancy Rigotti, MD Professor of Medicine, Harvard Medical School Director, Tobacco Research and Treatment Center, Massachusetts General Hospital nrigotti@partners.org
More informationHelping People Quit Tobacco
Helping People Quit Tobacco Peter Selby MBBS, CCFP, MHSc, ASAM Associate Professor, University of Toronto Clinical Director, Addictions Program, CAMH Principal Investigator, OTRU Disclosures! Grants/research
More informationTobacco Cessation, E- Cigarettes and Hookahs
Objectives Tobacco Cessation, E- Cigarettes and Hookahs Discuss evidence-based tobacco cessation interventions including pharmacologic options. Review e-cigarette and hookah facts and safety considerations.
More informationSmoking cessation interventions and services
Smoking cessation interventions and services Systematic reviews Public Health Internal Guideline Development August 2017 National Institute for Health and Care Excellence Disclaimer The recommendations
More informationHealth Promotion Service Project Overview
Health Promotion Service Project Overview TITLE NATIONAL TARGETS (e.g. To reduce the under 18 conception rate by 50% by 2010 ) Cornwall & Isles of Scilly Stop Smoking Service Reduce smoking prevalence
More informationSmoking cessation in mental health & addiction settings. Dr. Susanna Galea Community Alcohol & Drug Services, Auckland October 2013
Smoking cessation in mental health & addiction settings Dr. Susanna Galea Community Alcohol & Drug Services, Auckland October 2013 OVERVIEW Tobacco is the single most preventable cause of death in the
More informationSMOKING CESSATION WORKSHOP. Dr Mark Palayew December
SMOKING CESSATION WORKSHOP Dr Mark Palayew December 5 2016 Conflicts of Interest None Case 1 Mr. T is a 55 year old smoker 2 packs/day He has been smoking continuously since age 16 When he wakes up at
More informationVarenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?
Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks? Sonal Singh M.D., M.P.H, Johns Hopkins University Presented by: Sonal Singh, MD MPH September 19, 2012 1 CONFLICTS
More informationEvidence base, treatment policy and coverage in England. Ann McNeill
Evidence base, treatment policy and coverage in England Ann McNeill ann.mcneill@nottingham.ac.uk Smoking cessation support: 2008/9 43% of smokers sought help in quitting 671,259 smokers (~ 7%) set a quit
More informationPopulation-Based Smoking Cessation Strategies
Ontario Health Technology Assessment Series 2010; Vol. 10, No. 1 Population-Based Smoking Cessation Strategies A Summary of a Select Group of Evidence-Based Reviews Presented to the Ontario Health Technology
More informationSmoking Cessation: Where Are We Now? Nancy Rigotti, MD
Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org OVERVIEW The challenge for
More informationSmoking Cessation Pilot Program
Smoking Cessation Pilot Program Alyson Bettega Oral Health Therapist alysonb@nrch.com.au Aim of this session Increased awareness of cigarette smoking statistics Improved knowledge of smoking cessation
More informationMonth/Year of Review: March 2014 Date of Last Review: April 2012
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Copyright 2012 Oregon State University. All Rights
More informationSmoking Cessation A Clinicians Perspective. Jeff Wilson, MD
Smoking Cessation A Clinicians Perspective Jeff Wilson, MD Overview Tobacco control what we have accomplished and the road ahead Role of the health care professional Using pharmacotherapy Electronic cigarettes
More informationTreating Tobacco Use:
Treating Tobacco Use: Optimizing for the Best Outcomes Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org Primary
More informationSmoking cessation interventions and services
National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These
More informationSMOKING CESSATION IS HARD
POWER TO BREAK THE HOLD OF NICOTINE ADDICTION 1 SMOKING CESSATION IS HARD Most smokers try to quit 5-7 times before they are successful. 2 Why is it so hard to quit? Typical withdrawal symptoms from stopping
More informationPotential Costs and Benefits of Smoking Cessation for New Jersey
Potential Costs and Benefits of Smoking Cessation for New Jersey Jill S. Rumberger, PhD Assistant Professor Pennsylvania State University, Capital College, School of Public Affairs, Harrisburg, PA Christopher
More informationBreaking the Chains of Nicotine Dependence - A Breakthrough Approach
Breaking the Chains of Nicotine Dependence - A Breakthrough Approach Dr Rob Young Senior Lecturer & Consultant Physician Auckland Hospital, New Zealand Smoking Cessation in 2001 Smoking contributes to
More informationMotivating Smokers to Quit
Motivating Smokers to Quit Marc L. Steinberg, Ph.D. Assistant Professor of Psychiatry marc.steinberg@rutgers.edu Originally Released: August 13, 2013 Termination Date: September 12, 2014 Continuing Medical
More informationSmoking Cessation Interventions In Hospital Settings: Implementing the Evidence
Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence Nancy Rigotti, MD Tobacco Research & Treatment Center, General Medicine Division, Massachusetts General Hospital, Harvard
More informationElectronic cigarettes for smoking cessation
Electronic cigarettes for smoking cessation Results from the most recent Cochrane update Jamie Hartmann-Boyce*, Hayden McRobbie, Chris Bullen, Rachna Begh, Lindsay F Stead, Peter Hajek *Cochrane Tobacco
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 55 Lave Ave No, Worcester, MA 01655 www.umassmed.edu/tobacco 2016 Basic Skills for Working with Smokers 1 Table of
More informationProject TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.
Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Prevalence of Smoking and Cessation During Pregnancy In 2014, 14% in women with Medicaid coverage versus 3.6% of women with
More informationFuture challenges of tobacco dependence treatment from Japan experience
APACT 2013 Luncheon Seminar 4 (August 20 th, Makuhari, Chiba) Future challenges of tobacco dependence treatment from Japan experience Masakazu Nakamura, MD Osaka Center for Cancer and Cardiovascular Diseases
More informationPHARMACOTHERAPY OF SMOKING CESSATION
PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure
More informationAssociations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study
Page 1 of 11 Ferguson, SG; Brown, J; Frandsen, M; West, R; (2015) Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study. Addiction,
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table
More informationQuit rates among smokers who received pharmacist-provided pharmacotherapy and quitline services versus those who received only quitline services.
Quit rates among smokers who received pharmacist-provided pharmacotherapy and quitline services versus those who received only quitline services. Jill Augustine, PharmD, MPH 1 ; Ryan Seltzer, PhD 2 ; Martin
More informationInnovations. The effect of varenicline on cannabis use in cannabis users who also smoked tobacco
Innovations The effect of varenicline on cannabis use in cannabis users who also smoked tobacco David Newcombe 1,2, Natalie Walker 1,3, Janie Sheridan 1,4, Susanna Galea 1,5 1 The Centre for Addiction
More informationSmoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation
Smoking Cessation MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Objectives Tobacco use at population level Tobacco use and control around the world What works for managing tobacco use Common myths
More informationThe effectiveness of smoking cessation treatments used in the "real world"
Medizinische Fakultät The effectiveness of smoking cessation treatments used in the "real world" Daniel Kotz, PhD 11 March 2015 Heinrich-Heine-University Düsseldorf Maastricht University University College
More informationComparing the Cochrane review of electronic cigarettes to other meta-analyses
Comparing the Cochrane review of electronic cigarettes to other meta-analyses Jamie Hartmann-Boyce Cochrane Tobacco Addiction Group, Nuffield Department of Primary Care Health Sciences, University of Oxford.
More informationImportance of smoking cessation in improving the physical and mental health of people with mental illness
Importance of smoking cessation in improving the physical and mental health of people with mental illness Dr Jonathan Campion Director of Public Mental Health and Consultant Psychiatrist South London and
More informationPharmacological Treatments for Tobacco Users with Behavioral Health Conditions
Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Jill M Williams, MD Professor Psychiatry Director, Division Addiction Psychiatry Robert Wood Johnson Medical School Disclosures
More informationOXLEAS NHS FOUNDATION TRUST RESEARCH PROPOSAL
OXLEAS NHS FOUNDATION TRUST RESEARCH PROPOSAL Title of the Proposal Does using Motivational Interviewing (MI) in a group setting for people with severe mental illness (SMI) have a positive impact on smoking
More informationDrug Use Evaluation: Smoking Cessation
Drug Use Research & Management Program Oregon State University, 3303 SW Bond Av CH12C, Portland, Oregon 97239-4501 Phone 503-947-5220 Fax 503-494-1082 Drug Use Evaluation: Smoking Cessation Tobacco cessation
More informationInterventions to reduce harm from continued tobacco use(review)
Cochrane Database of Systematic Reviews Interventions to reduce harm from continued tobacco use (Review) Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T Lindson-Hawley N,
More informationVarenicline for smoking cessation: a review
Review article GP Rauniar 1, A Misra 2, DP Sarraf 2 1 Professor and Head, 2 Assistant Professor, Department of Clinical Pharmacology and Therapeutics, B.P. Koirala Institute of Health Sciences, Dharan,
More informationCessation Pathways Exploring Opportunities for Developing a Coordinated Smoking Cessation System in Ontario
Generating knowledge for public health E V A L U A T I O N NEWS Cessation Pathways Exploring Opportunities for Developing a Coordinated Smoking Cessation System in Ontario Introduction The process of quitting
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More informationSmoking Cessation. Hassan Sajjad Pulmonary & Critical Care
Smoking Cessation Hassan Sajjad Pulmonary & Critical Care Objectives Burden of Smoking Health Impacts of Smoking Smoking Cessation Motivational Interviewing Nicotine Replacement Therapy Bupropion Varenicline
More informationManagement of physical health conditions in adults with severe mental disorders
Management of physical health conditions in adults with severe mental disorders WHO GUIDELINES EVIDENCE PROFILES Tobacco cessation Weight management Substance use disorders Cardiovascular disease and cardiovascular
More informationHeather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health
Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health Disclosure Heather Dacus has no real or perceived vested interests that
More informationAdolescents and Tobacco Cessation
Adolescents and Tobacco Cessation Jonathan D. Klein, MD, MPH American Academy of Pediatrics Julius B. Richmond Center and the University of Rochester Rochester, NY Goal To review current evidence and perspectives
More informationTRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks
TRENDS IN TOBACCO And What Employers Can Do to Support Cessation Katy Tombaugh, Certified Tobacco Treatment Specialist Founder & CEO, Wellness Collective LEARNING OBJECTIVES Understand the types of tobacco
More informationHow best to get your patients to stop smoking. Dr Alex Bobak GP and GPSI in Smoking Cessation Wandsworth, London
How best to get your patients to stop smoking Dr Alex Bobak GP and GPSI in Smoking Cessation Wandsworth, London 1 2 Smoking can cause at least 14 different types of cancer 3 Smokers want to stop All smokers
More informationAnn G. is a 34-year-old mother of 2. Family Practice. Smoking cessation: Tactics that make a big difference
Smoking cessation: Tactics that make a big difference Quitlines, Web support, text messaging, and drugs improve quit rates if you and your staff set the stage Agnes O. Coffay, MD Intramural Research Program,
More informationSmoking Still Kills! (Figs for England)
Smoking Cessation Gay Sutherland (Clinical Psychologist) Visiting Researcher - Tobacco Research Unit Inst. of Psychiatry, Psychology & Neuroscience King s College London Smoking Still Kills! (Figs for
More informationWanting to Get Pregnant
Continuing Medical Education COPD Case Presentation LEARNING OBJECTIVES Those completing this activity will receive information that should allow them to Assist a patient in developing a quit plan; Advise
More informationTobacco Dependence Treatment From Neurobiology through Public Policy
Tobacco Dependence Treatment From Neurobiology through Public Policy Mary Ellen Wewers, PhD, MPH, RN Professor Emerita The Ohio State University College of Public Health Disclosures Funding from the National
More informationCombined pharmacotherapy and behavioural interventions for smoking cessation(review)
Cochrane Database of Systematic Reviews Combined pharmacotherapy and behavioural interventions for smoking cessation(review) Stead LF, Koilpillai P, Fanshawe TR, Lancaster T Stead LF, Koilpillai P, Fanshawe
More informationKnowledge and attitudes of french cardiologists about smoking. Olivier Stora, cardiologist, Nantes
Knowledge and attitudes of french cardiologists about smoking Olivier Stora, cardiologist, Nantes Disclosure Statement of Financial Interest I currently have, or have had over the last two years, an affiliation
More informationTobacco Use and Cessation in Psychiatric Patients
Tobacco Use and Cessation in Psychiatric Patients John Spangler, MD, MPH Professor of Family Medicine Wake Forest School of Medicine NCPA, October 2015 Disclosure I have no relevant financial relationship
More informationCore Competencies - Smoking Cessation Fundamentals
Core Competencies - Smoking Cessation Fundamentals This training standard was developed for the National Training Service (NTS) Alliance in consultation with subject matter experts. The purpose of this
More information5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.
0 11 Key Messages 1. Ask and document smoking status for all patients. 2. Provide brief advice on quit smoking at every visit to all smokers. 3. Use individual, group and telephone counselling approaches,
More informationRandomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up
Addictive Behaviors 32 (2007) 3060 3064 Short communication Randomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up Michael Ussher a,, Robert West
More informationStrategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings
Strategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings Antoine Douaihy, MD Associate Professor of Psychiatry University of Pittsburgh School of Medicine
More informationEvidence-based Practice
Evidence-based Practice Michael V. Burke, EdD Assistant Professor of Medicine Treatment Program Coordinator Mayo Clinic Nicotine Dependence Center May, 2013 Learning objectives At the end of this presentation
More information4 Approximately $61.7 million was spent on the national tobacco control programme in 2014/15.
In Confidence Office of the Associate Minister of Health Chair, Cabinet Social Policy Committee Report back on New Zealand s Tobacco Control Programme Proposal 1 This paper provides a report back on the
More informationDownloaded from:
Free, C; Whittaker, R; Knight, R; Abramsky, T; Rodgers, A; Roberts, IG (2009) Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tobacco control, 18 (2). pp.
More informationKeywords: tobacco, cigarette smoke, nicotine, dopamine, smoking cessation, acethylcholine, varenicline (champix )
Review Article and Clinical Experience: ENICLINE (CHAMPIX ) : A BREAKTHROUGH FOR SMOKING CESSATION TREATMENT (An α4ß2 Nicotinic Acethylcholine Receptor Partial Agonist) Askandar Tjokroprawiro Diabetes
More informationAre we missing an opportunity to improve. smoking cessation rates for pregnant women? JHD. Lizanne C Siqueira
Are we missing an opportunity to improve smoking cessation rates for pregnant women? Lizanne C Siqueira The University of Notre Dame, School of Medicine, Ballarat Clinical School, Ballarat, VIC, Australia.
More informationUpdate on SMOKING CESSATION. Supporting the PHO Performance Programme. 38 BPJ Issue 33
Update on SMOKING CESSATION Supporting the PHO Performance Programme 38 BPJ Issue 33 Key concepts The rate of smoking among New Zealanders is slowly reducing, however more work needs to be done to further
More informationA randomised trial of glucose tablets to aid smoking cessation
DOI 10.1007/s00213-009-1692-3 ORIGINAL INVESTIGATION A randomised trial of glucose tablets to aid smoking cessation Robert West & Sylvia May & Andy McEwen & Hayden McRobbie & Peter Hajek & Eleni Vangeli
More informationEMERGING ISSUES IN SMOKING CESSATION
EMERGING ISSUES IN SMOKING CESSATION Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe, CM, MD University
More informationSmoking Cessation 28/3/2014. M.Valliappan Senior Resident Department of Pulmonary Medicine
Smoking Cessation 28/3/2014 M.Valliappan Senior Resident Department of Pulmonary Medicine Overview Understanding harms of smoking Pathophysiology and basics of nicotine addiction Smoking cessation Non-pharmacologic
More informationReducing Tobacco Use and Secondhand Smoke Exposure: Quitline Interventions
Reducing Tobacco Use and Secondhand Smoke Exposure: Quitline Interventions Summary Evidence Table Evidence Offering Medication (NRT) through Quitlines and An et al. (2006) Minnesota; smoked five or more
More informationThis standard is not designed to be prescriptive of how, when or in what format training is delivered although, some guidelines are included.
Using Medicines (or medicines refresher) This is a training standard developed for the National Training Service (NTS) Alliance. This standard has been written in consultation with subject matter experts.
More informationMost people who smoke in Canada
CME Review Managing smoking cessation CMAJ Robert D. Reid PhD MBA, Gillian Pritchard MPH, Kathryn Walker MScPT, Debbie Aitken BScN, Kerri-Anne Mullen PhD, Andrew L. Pipe MD CMAJ Podcasts: author interview
More informationSmoking cessation interventions and strategies. Technical report
Volume 4 Issue 8 2008 ISSN 1833-7732 Smoking cessation interventions and strategies Technical report Craig Lockwood Amanda O Connell Phillip Thomas JBI Best Practice Technical Reports Joanna Briggs Institute
More informationIf treatment for tobacco addiction was evidence-based, what would it look like? Robert West University College London YORK, November 2005
If treatment for tobacco addiction was evidence-based, what would it look like? Robert West University College London YORK, November 2005 Outline What is tobacco addiction and what is the goal of treatment?
More informationTobacco & Nicotine: Addiction and Treatment
Tobacco & Nicotine: Addiction and Treatment Tim McAfee, MD, MPH Chief Medical Officer - Free & Clear 206-876-2551 - tim.mcafee@freeclear.com Affiliate Assistant Professor, University of Washington, School
More informationSupporting smokers with mental health problems
Collaboration for Leadership in Applied Health Research and Care South London (CLAHRC South London) Supporting smokers with mental health problems Ann McNeill, Professor of Tobacco Addiction Dr Debbie
More informationRelapse prevention interventions for smoking cessation(review)
Cochrane Database of Systematic Reviews Relapse prevention interventions for smoking cessation (Review) HajekP,SteadLF,WestR,JarvisM,Hartmann-BoyceJ,LancasterT Hajek P, Stead LF, West R, Jarvis M, Hartmann-Boyce
More informationIn its 2014 report, The Health Consequences of Smoking 50
Paul Bornemann, MD; Amirarsalan Eissa, MD, MPH; Scott M. Strayer, MD, MPH University of South Carolina Department of Family and Preventive Medicine, Columbia (Drs. Bornemann and Strayer); St. Vincent Charity
More informationUsing Stop Smoking Medicines
Using Stop Smoking Medicines This training standard was developed for the National Training Service (NTS) Alliance in consultation with subject matter experts. The purpose of this training standard is
More informationThe impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in Englandadd_
RESEARCH REPORT doi:10.1111/j.1360-0443.2011.03494.x The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in Englandadd_3494 1827..1834 Lisa Szatkowski 1,
More informationImproving smoking cessation approaches at the individual level
Strategic directions and emerging issues in tobacco control 1 Primary Care Clinical Sciences, University of Birmingham, Birmingham, UK 2 UK Centre for Tobacco Control Studies, Division of Epidemiology
More informationEvaluation of ASC. Asian Smokefree Communities Pilot. Six Month Smoking Cessation Outcomes
Evaluation of ASC Asian Smokefree Communities Pilot Six Month Smoking Cessation Outcomes July 2007 Title: Evaluation of ASC (Asian Smokefree Communities) Pilot: Six-month smoking cessation outcomes, July
More informationPractical advice on smoking cessation: Patients with long-term conditions
Practical advice on smoking cessation: Patients with long-term conditions Tracy Kirk Primary Care Based Respiratory Nurse Consultant This symposium is organised and funded by Pfizer Prescribing Information
More informationBrief Intervention for Smoking Cessation. National Training Programme
Brief Intervention for Smoking Cessation National Training Programme Introduction Monitor tobacco use and prevention policies Protect people from tobacco smoke Offer help to quit tobacco use Warn about
More informationReview: Pharmacotherapy for smoking cessation
Focused review Review: Pharmacotherapy for smoking cessation Chok Limsuwat MD, Shigeki Saito MD, MSCR, Karin Halvorson MD Abstract Smoking is associated with numerous cancers and atherosclerosis. Smoking
More informationTobacco Control Tūranga Update Focus on reducing nicotine content in tobacco to help smokers quit
Tobacco Control Tūranga Update Focus on reducing nicotine content in tobacco to help smokers quit Professor Chris Bullen and Dr Marewa Glover, Co-Directors, Tobacco Control Research Turanga 18 March 2015
More informationFactors associated with differences in quit rates between 'specialist' and 'community' stop-smoking practitioners in the English Stop-Smoking Services
University of Wollongong Research Online Faculty of Engineering and Information Sciences - Papers: Part A Faculty of Engineering and Information Sciences 2013 Factors associated with differences in quit
More informationThe 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):
Smoking Cessation Module Tobacco use is the single greatest preventable cause of chronic diseases and premature deaths worldwide. The Canadian Cancer Society reports that tobacco product use is responsible
More information8/9/18. Objectives. Smoking. Disclosure Statement. The presenters have no real or potential conflicts of interest related to the presentation topic.
Disclosure Statement Multifaceted Smoking Cessation Strategies for Nurse Practitioners The presenters have no real or potential conflicts of interest related to the presentation topic. Dr. Susan Chaney,
More informationResearch Review PRODUCT REVIEW. About the Reviewer
UPDATED BASED ON LATEST DATA Research Review PRODUCT REVIEW Varenicline [Champix ] About the Reviewer Dr Hayden McRobbie MB ChB (Otago) PhD (London) Hayden is based both in New Zealand, where he is a Senior
More informationThe Quit Clinic As an Anti-smoking Advocacy Tool
The Quit Clinic As an Anti-smoking Advocacy Tool Associate Professor Chanchai Sittipunt MD Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Faculty of Medicine Chulalongkorn
More informationThis review is based on a presentation from the. Smoking cessation and COPD CLINICAL YEAR IN REVIEW. Philip Tønnesen
Eur Respir Rev 2013; 22: 127, 37 43 DOI: 10.1183/09059180.00007212 CopyrightßERS 2013 CLINICAL YEAR IN REVIEW Smoking cessation and COPD Philip Tønnesen ABSTRACT: The mainstay in smoking cessation is counselling
More informationSystematic Review Search Strategy
Registered Nurses Association of Ontario Clinical Best Practice Guidelines Program Integrating Tobacco Interventions into Daily Practice (2017) Third Edition Systematic Review Search Strategy Concurrent
More informationFax to Quit: A Model for Delivery of Tobacco Cessation Services to Wisconsin Residents
Fax to Quit: A Model for Delivery of Tobacco Cessation Services to Wisconsin Residents Robin J. Perry, BS, CHES; Paula A. Keller, MPH; Dave Fraser, MS; Michael C. Fiore, MD, MPH ABSTRACT Research has shown
More informationEdinburgh Research Explorer
Edinburgh Research Explorer Internet-based interventions for smoking cessation Citation for published version: Civljak, M, Sheikh, A, Stead, LF & Car, J 2010, 'Internet-based interventions for smoking
More informationSmoking Cessation Guidelines
New Zealand Smoking Cessation Guidelines This project was lead by the Clinical Trials Research Unit, The University of Auckland, in association with the guidelines development team. Citation: Ministry
More information